REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innovispharma Cia.Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Innovispharma Cia.Ltda Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Innovispharma Cia.Ltda is based in Ecuador, with the head office in Cuenca. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 04, 2018. It currently has a total number of 3 (2023) employees. From the latest financial highlights, Innovispharma Cia.Ltda reported a net sales revenue drop of 52.71% in 2023. A growth of 4.66% was recorded in its total assets. Innovispharma Cia.Ltda’s net profit margin increased by 0.31% in 2023.

Headquarters
Av los Andes 2-45
Cuenca; Azuay;

Contact Details: Purchase the Innovispharma Cia.Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Innovispharma Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Innovispharma Cia.Ltda report to view the information.
Registered Capital:
Purchase the Innovispharma Cia.Ltda report to view the information.
Incorporation Date:
April 04, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Innovispharma Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-52.71%▼
Total operating revenue
-52.71%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-49.02%▼
Total assets
4.66%▲
Total equity
39.22%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.31%▲
Return on Equity (ROE)
19.68%▲
Quick Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo